Health CanadaGeneral Alert
TECENTRIQ (atezolizumab) - Risk of Myocarditis
Published: February 14, 2018Recall ID: 58038Category: generalCountry: Canada
Product Description & Identification
TECENTRIQ (atezolizumab) - Risk of Myocarditis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 58038 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/tecentriq-atezolizumab-risk-myocarditis |
| Title | TECENTRIQ (atezolizumab) - Risk of Myocarditis |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2018-02-14 |
| Organization | Marketed health products |